Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases

PURPOSE: To (1) examine the occurrence and concentrations of aPS/PT and aPL in inflammatory bowel disease (IBD) patients at the beginning of and during anti-TNF-alpha therapy with infliximab; (2) investigate the link of the aPS/PT and aPL presence with antibodies to infliximab (ATI) formation; and (...

Descripción completa

Detalles Bibliográficos
Autores principales: Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389083/
https://www.ncbi.nlm.nih.gov/pubmed/26000139
http://dx.doi.org/10.1007/s13317-012-0045-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389083/
https://www.ncbi.nlm.nih.gov/pubmed/26000139
http://dx.doi.org/10.1007/s13317-012-0045-0

Ejemplares similares